Modification of oral contraceptive relationships on breast cancer risk by selected factors among younger women

Contraception

Volumn 55, Issue 4, 1997, Pages 197-203

  Brinton, Louise A ^a   Gammon, Marilie D ^b   Malone, Kathleen E ^c   Schoenberg, Janet B ^d   Daling, Janet R ^c   Coates, Ralph J ^e  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Columbia Univ Sch of Public Health ^*  (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d Special Epidemiology Program   (United States)

^e EMORY UNIVERSITY   (United States)

Author keywords

Breast cancer; Interactions; Oral contraceptives; Risk factors

Indexed keywords

ALCOHOL; ORAL CONTRACEPTIVE AGENT;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BODY SIZE; BREAST CANCER; BREAST DISEASE; CANCER RISK; CAUCASIAN; CONTROLLED STUDY; DRUG ALCOHOL INTERACTION; FAMILY HISTORY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NEGRO; ORAL DRUG ADMINISTRATION; RACE DIFFERENCE; RISK FACTOR;

AMERICAS; BLACKS--WOMEN; BREAST CANCER; CANCER; CASE CONTROL STUDIES; CONTRACEPTION; CONTRACEPTIVE METHODS; CULTURAL BACKGROUND; DEMOGRAPHIC FACTORS; DEVELOPED COUNTRIES; DISEASES; ETHNIC GROUPS; EVALUATION; FAMILY PLANNING; NEOPLASMS; NORTH AMERICA; NORTHERN AMERICA; ORAL CONTRACEPTIVES; ORAL CONTRACEPTIVES, COMBINED; POPULATION; POPULATION CHARACTERISTICS; RESEARCH METHODOLOGY; RESEARCH REPORT; RISK ASSESSMENT; STUDIES; UNITED STATES; WHITES--WOMEN;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; BIOPSY; BODY MASS INDEX; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CONTINENTAL POPULATION GROUPS; CONTRACEPTIVES, ORAL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MENARCHE; RISK FACTORS;

EID: 0030866402     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-7824(97)00012-7     Document Type: Article

References (40)

1. Meirik O, Lund E, Adami H-O, Bergstrom R, Christoffersen T, Bergsjo P. Oral contraceptive use and breast cancer in young women. A joint national case-control study in Sweden and Norway. Lancet 1986;2:650-4.
2. Miller DR, Rosenberg L, Kaufman DW, Stolley PD, Warshauer ME, Shapiro S. Breast cancer before age 45 and oral contraceptive use: new findings. Am J Epidemiol 1989;129:269-80.
3. Palmer JR, Rosenberg L, Rao RS, et al. Oral contraceptive use and breast cancer risk among African-American women. Cancer Causes Control 1995;6:321-31.
4. Rookus MA, van Leeuwen FE, the Netherlands Oral Contraceptives and Breast Cancer Study Group. Oral contraceptives and risk of breast cancer in women aged 20-54 years. Lancet 1994;344:844-51.
5. Rosenberg L, Palmer JR, Rao RS, et al. Case-control study of oral contraceptive use and risk of breast cancer. Am J Epidemiol 1996;143:25-37.
6. UK National Case-Control Study. Oral contraceptive use and breast cancer risk in young women. Lancet 1989;6:973-82.
7. White E, Malone KE, Weiss NS, Daling JR. Breast cancer among young US women in relation to oral contraceptive use. J Natl Cancer Inst 1994;86:505-14.
8. UK National Case-Control Study Group. Oral contraceptive use and breast cancer risk in young women: subgroup analyses. Lancet 1990;335:1507-9.
9. La Vecchia C, Parazzini F, Negri E, et al. Breast cancer and combined oral contraceptives: an Italian case-control study. Eur J Cancer Clin Oncol 1989;25:1613-8.
10. Pike MC, Henderson BE, Casagrande JT, Rosario I, Gray GE. Oral contraceptive use and early abortion as risk factors for breast cancer in young women. Br J Cancer 1981;43:72-6.
11. Rohan TE, McMichael AJ. Oral contraceptive agents and breast cancer: a population-based case-control study. Med J Aus 1988;149:520-6.
12. Meirik O, Farley TMM, Lund E, Adami H-O, Christoffersen T, Bergsjo P. Breast cancer and oral contraceptives: patterns of risk among parous and nulliparous women - further analysis of the Swedish-Norwegian material. Contraception 1989;39:471-5.
13. Schildkraut JM, Hulka BS, Wilkinson WE. Oral contraceptives and breast cancer: a case-control study with hospital and community controls. Obstet Gynecol 1990;76:395-402.
14. Stadel BV, Lai S, Schlesselman JJ, Murray P. Oral contraceptives and premenopausal breast cancer in nulliparous women. Contraception 1988;38:287-99.
15. Brinton LA, Daling JR, Liff J, et al. Oral contraceptives and breast cancer risk. J Natl Cancer Inst 1995;87:827-35.
16. Thompson WD. Statistical analysis of case-control studies. Epidemiol Rev 1994;16:33-50.
17. The Centers for Disease Control Cancer and Steroid Hormone Study. Long-term oral contraceptive use and the risk of breast cancer. JAMA 1983;249:1591-5.
18. Ewertz M. Oral contraceptives and breast cancer risk in Denmark. Eur J Cancer 1992;28A:1176-81.
19. Harris RE, Zang EA, Wynder EL. Oral contraceptives and breast cancer risk: a case-control study. Int J Epidemiol 1990;19:240-6.
20. Paul C, Skegg DCG, Spears GFS. Oral contraceptives and risk of breast cancer. Int J Cancer 1990;46:366-73.
21. Primic-Zakelj M, Evstifeeva T, Ravnihar B, Boyle P. Breast cancer risk and oral contraceptive use in Slovenian women aged 25 to 54. Int J Cancer 1995;62:414-20.
22. Romieu I, Willett WC, Colditz GA, et al. Prospective study of oral contraceptive use and risk of breast cancer in women. J Natl Cancer Inst 1989;81:1313-21.
23. Rosenberg L, Palmer JR, Clarker EA, Shapiro S. A case-control study of the risk of breast cancer in relation to oral contraceptive use. Am J Epidemiol 1992; 136:1437-44.
24. Stanford JL, Brinton LA, Hoover RN. Oral contraceptives and breast cancer: results from an expanded case-control study. Br J Cancer 1989;60:375-81.
25. Tavani A, Negri E, Franceschi S, Parazzini F, La Vecchia C. Oral contraceptives and breast cancer in Northern Italy. Final report from a case-control study. Br J Cancer 1993;68:568-71.
26. Vessey M, Baron J, Doll R, McPhearson K, Yeates D. Oral contraceptives and breast cancer: final report of an epidemiologic study. Br J Cancer 1989,47:455-62.
27. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Breast cancer and combined oral contraceptives: results from a multinational study. Br J Cancer 1990;61:110-9.
28. Velentgas P, Daling JR. Risk factors for breast cancer in younger women. Monogr Natl Cancer Inst 1994;16:15-22.
29. Gammon MD, Schwartz AV, Douglass WD. Age-specific effects for breast cancer among black women under age 55. Cancer Epidemiol Biomark Prev; in press.
30. Murray PP, Stadel BV, Schlesselman JJ. Oral contraceptive use in women with a family history of breast cancer. Obstet Gynecol 1899;73:977-83.
31. Claus EB. Genetic epidemiology of breast cancer in younger women. Monogr Natl Cancer Inst 1994;16:49-53.
32. Hunter DJ, Willett WC. Diet, body size, and breast cancer. Epidemiol Rev 1993;15:110-32.
33. Rosenberg L, Metzger LS, Palmer JR. Alcohol consumption and risk of breast cancer: a review of the epidemiologic evidence. Epidemiol Rev 1993;15:133-44.
34. Hankinson SE, Willett WC, Manson JE, et al. Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women. J Natl Cancer Inst 1995;87:1297-302.
35. Reichman ME, Judd JT, Longcope C, et al. Effects of alcohol consumption on plasma and urinary hormone concentrations in premenopausal women. J Natl Cancer Inst 1993;85:722-7.
36. Vessey MP, McPherson K, Yeates D, Doll R. Oral contraceptive use and abortion before first term pregnancy in relation to breast cancer risk. Br J Cancer 1982;45:327-31.
37. Weinstein AL, Mahoney MC, Nasca PC, Leske MC, Varma AO. Breast cancer risk and oral contraceptive use: results from a large case-control study. Epidemiol 1991;2:353-8.
38. Stadel BV, Schlesselman JJ. Oral contraceptive use and the risk of breast cancer in women with a "prior" history of benign breast disease. Am J Epidemiol 1986; 123:373-82.
39. Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 1985;312:146-51.
40. Krieger N, Hiatt RA. Risk of breast cancer after benign breast diseases. Variation by histologic type, degree of atypia, age at biopsy, and length of follow-up. Am J Epidemiol 1992;135:619-31.